The results from two clinical trials on the treatment of latent tuberculosis (TB) were recently published in the New England Journal of Medicine. The studies from the Research-Institute of the McGill University Health Centre (RI-MUHC; Montreal, Canada) demonstrated that a shorter treatment was more safe and effective in all age categories.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.